-The Hindu Indians are living longer than before, but illness and disability of a very high order and relatively early death remain severe health care challenges. What should concern health care planners and providers is that India is lagging behind many of its South Asian neighbours, including China, in key health parameters. Life expectancy at birth in India, that was 58.3 in 1990, has gone up to 65.2 in 2010. However, most...

-The Times of India GHAZIABAD: The air in Ghaziabad, even in relatively greener areas such as Indirapuram, Vaishali and Kaushambi, is nothing short of a poisonous cocktail. Prolonged exposure to the air in the city, among the top five 'most critically polluted cities' in the country, can lead to a number of respiratory diseases, most of which directly affect the lungs. Centre of Science Environment's (CSE) analysis of government data and Global...

-The Times of India Even as one in four deaths worldwide in 2010 was caused by heart disease or stroke the top two killers that have remained constant for the past 40 years human mortality caused by climate change has shown the most dangerous spurt over the last four decades. The Global Burden of Disease Study, 2010, published by the British medical journal, The Lancet, on Thursday shows that there has been...

-The Telegraph People who stop smoking before the age of 40 may on average gain an extra 10 years of life expectancy, according to a study that researchers say has relevance to India where people typically quit only after falling ill. A British study described as the world’s largest to assess the hazards of smoking and the benefits of quitting has shown that quitting before 40 can help avoid excess mortality observed...

-Live Mint There are also ways in which we can help Indian institutions that have come to us seeking access to our technologies Bangalore: A key perception change is emerging in the global pharmaceutical industry on the long-established divide between the so-called generics and innovative business. While the two are still at loggerheads in several developed as well as developing markets, the world’s top drugmakers are reinventing the wheel. Paris-based Sanofi SA,...